🧪 Gladstone Institutes prize: Trialign by Jules Park (Toronto, Canada) and Neil Wang (San Francisco, CA)
A clinical trial matcher for cancer patients that reads their medical records and finds the studies they qualify for today.
Video
Trialign, created by Jules Park (Toronto, Canada) and Neil Wang (San Francisco…
Brief
Trialign, developed by Jules Park (Toronto) and Neil Wang (San Francisco), won a Gladstone Institutes prize (posted 2026-07-17). The tool reads cancer patients’ medical records and identifies clinical studies they qualify for right now, and the announcement includes a video demo of the system’s real-time matching capabilities.
Why it matters
Trialign, created by Jules Park (Toronto, Canada) and Neil Wang (San Francisco, CA), won a Gladstone Institutes prize announced 2026-07-17.
Key details
- Trialign is a clinical-trial matcher for cancer patients that ingests patients' medical records and returns studies they currently qualify for.
- The announcement included a demonstration video showing Trialign's real-time matching workflow for identifying eligible trials from medical records.